1. Home
  2. KOSS vs RFL Comparison

KOSS vs RFL Comparison

Compare KOSS & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

N/A

Current Price

$4.08

Market Cap

39.3M

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.50

Market Cap

61.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
KOSS
RFL
Founded
1953
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Real Estate
Sector
Consumer Staples
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
39.3M
61.1M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
KOSS
RFL
Price
$4.08
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.3K
91.0K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
10.00
28.28
EPS
N/A
N/A
Revenue
$12,624,170.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.93
43.96
52 Week Low
$4.00
$1.12
52 Week High
$8.59
$3.19

Technical Indicators

Market Signals
Indicator
KOSS
RFL
Relative Strength Index (RSI) 43.85 65.63
Support Level $4.07 $1.41
Resistance Level $5.04 $1.63
Average True Range (ATR) 0.14 0.10
MACD -0.00 0.02
Stochastic Oscillator 22.37 71.25

Price Performance

Historical Comparison
KOSS
RFL

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: